GOSS (Gossamer Bio) EBITDA Margin %: -257.61% (As of Mar. 2026)


GOSS Gossamer Bio Inc GOSS
16 GF Score
Price $0.17
! 5 Warning Signs
View Full Analysis

What is Gossamer Bio EBITDA Margin %?

Gossamer Bio GOSS -2.82% 16 EBITDA Margin % is -257.61% as of Mar. 2026. GuruFocus rates GOSS with a GF Score™ of 16/100. The stock has 5 warning signs investors should review. Among 945 Biotechnology companies, Gossamer Bio ranks worse than 66.46% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Gossamer Bio's EBITDA for the three months ended in Mar. 2026 was $-43.68 Mil. Gossamer Bio's Revenue for the three months ended in Mar. 2026 was $16.96 Mil. Therefore, Gossamer Bio's EBITDA margin for the quarter that ended in Mar. 2026 was -257.61%.

Gossamer Bio  (NAS:GOSS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Gossamer Bio EBITDA Margin % Related Terms

Gossamer Bio EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Gossamer Bio's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gossamer Bio EBITDA Margin % Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -34.84 -326.93

Gossamer Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -339.27 -307.39 -340.40 -321.39 -257.61

GOSS vs TIL, ATYR, HYPD: EBITDA Margin % Comparison

For the Biotechnology subindustry, Gossamer Bio's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gossamer Bio EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gossamer Bio's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Gossamer Bio's EBITDA Margin % falls into.


GOSS
16GF Score
Gossamer Bio Inc GOSS
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gossamer Bio EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Gossamer Bio's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-158.467/48.471
=-326.93 %

Gossamer Bio's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-43.677/16.955
=-257.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -257.61% mean?
Gossamer Bio (GOSS) has a EBITDA Margin % of -257.61% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gossamer Bio and its competitors. According to the industry distribution chart, Gossamer Bio ranks #628 out of 945 companies in the Biotechnology industry, placing it in the top 66.5%.
Is Gossamer Bio's EBITDA Margin % too high?
Gossamer Bio's current EBITDA Margin % is -257.61%. Based on the distribution chart, Gossamer Bio ranks #628 out of 945 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Gossamer Bio has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Gossamer Bio's EBITDA Margin % compare to TIL and ATYR?
According to the Biotechnology industry distribution chart, Gossamer Bio ranks #628 out of 945 companies for EBITDA Margin %. This places Gossamer Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gossamer Bio and its competitors. Gossamer Bio's current EBITDA Margin % is -257.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gossamer Bio stock overvalued right now?
Gossamer Bio (GOSS) has a current EBITDA Margin % of -257.61%. The current EBITDA Margin % is -257.61%. Gossamer Bio's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Gossamer Bio (GOSS), the current EBITDA Margin % is -257.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gossamer Bio Business Description

Other Exchanges 4GB:Germany
Address 3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
16GF Score

Get the complete analysis for GOSS

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price